ClearBridge Investments
TGTX icon

ClearBridge Investments’s TG Therapeutics TGTX Stock Holding History

ClearBridge Investments’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146M Sell
2,650,192
-560,738
-17% -$22.9M 0.12% 169
2026
Q1 		$107M Sell
3,210,930
-237,103
-7% -$7.07M 0.09% 201
2025
Q4 		$103M Sell
3,448,033
-1,196,442
-26% -$39.1M 0.08% 236
2025
Q3 		$168M Buy
4,644,475
+1,591,919
+52% +$52.4M 0.13% 170
2025
Q2 		$110M Buy
3,052,556
+408,099
+15% +$15.2M 0.09% 216
2025
Q1 		$104M Buy
2,644,457
+809,330
+44% +$27.2M 0.09% 219
2024
Q4 		$55.2M Buy
+1,835,127
New +$52.7M 0.04% 306

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ClearBridge Investments's TGTX Position: Q2 2026 in Review

ClearBridge Investments reduced its TG Therapeutics (TGTX) stake by 17% in Q2 2026, selling an estimated $22.9M and leaving 2,650,192 shares worth $146M. The position accounts for 0.12% of the portfolio, ranked #169.

ClearBridge Investments first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $168M in Q3 2025. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • ClearBridge Investments held 2,650,192 shares of TG Therapeutics worth $146M as of Q2 2026.
  • ClearBridge Investments sold 560,738 TG Therapeutics shares in Q2 2026, an estimated $22.9M.
  • TG Therapeutics made up 0.12% of ClearBridge Investments's portfolio in Q2 2026, its #169 holding.
  • ClearBridge Investments first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • ClearBridge Investments's TG Therapeutics position peaked at $168M in Q3 2025.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.